Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M B Bottorff

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Clinical Pharmacokinetics|November 1, 1991
Pharmacokinetic interactions with calcium channel antagonists (Part I)K D Schlanz, S A Myre, M B Bottorff
Clinical Pharmacy|February 1, 1987
Interference with digoxin immunoassaysM B Bottorff, S J Phelps, T J Hoon
Drug Intelligence & Clinical Pharmacy|April 1, 1983
High-dose procainamide in chronic renal failureM B Bottorff, C S Kuo, R L Batenhorst
Clinical Pharmacy|July 1, 1983
Mechanisms and control of ventricular tachyarrhythmiasR L Batenhorst, M B Bottorff, C S Kuo
Biopharmaceutics & Drug Disposition|May 1, 1987
Comparison of high pressure liquid chromatography and fluorescence polarization immunoassay to assess quinidine pharmacokineticsM B Bottorff, R L Lalonde, A B Straughn
The Journal of Pediatrics|January 1, 1987
Effect of age and serum creatinine on endogenous digoxin-like substances in infants and childrenS J Phelps, C A Kamper, M B Bottorff, et al.
Chest|August 1, 1989
Calcium channel blockers as inhibitors of drug metabolismB A Hunt, T H Self, R L Lalonde, et al.
The Journal of Pediatrics|May 1, 1984
Acute rifampin overdose: a pharmacokinetic study and review of the literatureP Wong, M B Bottorff, R W Heritage, et al.
Journal of Pharmaceutical Sciences|July 1, 1987
Nonlinear pharmacokinetics of unbound propranolol after oral administrationR J Straka, R L Lalonde, J A Pieper, et al.
Journal of Cardiovascular Pharmacology|November 1, 1990
Altered beta-adrenergic sensitivity and protein binding to 1-propranolol in the elderlyD M Tenero, M B Bottorff, B S Burlew, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Clinical Pharmacokinetics|November 1, 1991
Pharmacokinetic interactions with calcium channel antagonists (Part I)K D Schlanz, S A Myre, M B Bottorff
Clinical Pharmacy|February 1, 1987
Interference with digoxin immunoassaysM B Bottorff, S J Phelps, T J Hoon
Drug Intelligence & Clinical Pharmacy|April 1, 1983
High-dose procainamide in chronic renal failureM B Bottorff, C S Kuo, R L Batenhorst
Clinical Pharmacy|July 1, 1983
Mechanisms and control of ventricular tachyarrhythmiasR L Batenhorst, M B Bottorff, C S Kuo
Biopharmaceutics & Drug Disposition|May 1, 1987
Comparison of high pressure liquid chromatography and fluorescence polarization immunoassay to assess quinidine pharmacokineticsM B Bottorff, R L Lalonde, A B Straughn
The Journal of Pediatrics|January 1, 1987
Effect of age and serum creatinine on endogenous digoxin-like substances in infants and childrenS J Phelps, C A Kamper, M B Bottorff, et al.
Chest|August 1, 1989
Calcium channel blockers as inhibitors of drug metabolismB A Hunt, T H Self, R L Lalonde, et al.
The Journal of Pediatrics|May 1, 1984
Acute rifampin overdose: a pharmacokinetic study and review of the literatureP Wong, M B Bottorff, R W Heritage, et al.
Journal of Pharmaceutical Sciences|July 1, 1987
Nonlinear pharmacokinetics of unbound propranolol after oral administrationR J Straka, R L Lalonde, J A Pieper, et al.
Journal of Cardiovascular Pharmacology|November 1, 1990
Altered beta-adrenergic sensitivity and protein binding to 1-propranolol in the elderlyD M Tenero, M B Bottorff, B S Burlew, et al.
Pageof 4